Current Report Filing (8-k)
25 June 2022 - 6:33AM
Edgar (US Regulatory)
0000720154
false
0000720154
2022-06-20
2022-06-20
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
June 20, 2022
INOTIV, INC. |
(Exact name of registrant as specified in its charter) |
Indiana |
|
0-23357 |
|
35-1345024 |
(State or other jurisdiction of
incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
2701 KENT AVENUE
WEST LAFAYETTE, indiana |
|
47906-1382 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant's telephone number, including area code: (765) 463-4527
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title
of each class |
Trading Symbol(s) |
Name of each
exchange
on which registered |
Common Shares |
NOTV |
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company ¨
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
Compensatory Arrangements of Certain Officers. |
Inotiv, Inc. (the “Company”)
has announced that James Harkness, the Company’s Chief Operating Officer, Research Models & Services, will be retiring from
the Company, effective on September 30, 2022.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
Exhibit Index
Exhibit No. |
|
Description |
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.
|
INOTIV, INC. |
|
|
|
|
|
|
Date: June 24, 2022 |
By: |
/s/ Beth A. Taylor |
|
|
Chief Financial Officer, |
|
|
Vice President—Finance |
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioanalytical Systems (NASDAQ:BASI)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bioanalytical Systems Inc (NASDAQ): 0 recent articles
More Inotiv, Inc. News Articles